BankInvest

Type

Hedge fund

Status

Active

Location

Copenhagen, Denmark

Total investments

19

Average round size

20M

Portfolio companies

16

Rounds per year

0.54

Lead investments

3

Follow on index

0.16

Exits

7

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareHealth DiagnosticsManufacturingPharmaceuticalTherapeuticsEnergySolarEnergy Efficiency

Summary

BankInvest is the famous Corporate Investor, which was founded in 1989. The fund was located in Europe if to be more exact in Denmark. The main office of represented Corporate Investor is situated in the Copenhagen.

We also calculated 11 valuable employees in our database.

The top activity for fund was in 2008. Speaking about the real fund results, this Corporate Investor is 2 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. When the investment is from BankInvest the average startup value is 50-100 millions dollars. The higher amount of exits for fund were in 2006. This BankInvest works on 26 percentage points more the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the BankInvest, startups are often financed by Scottish Equity Partners, 3i Group, TTP Ventures. The meaningful sponsors for the fund in investment in the same round are Scottish Equity Partners, Forbion Capital Partners, EnerTech Capital. In the next rounds fund is usually obtained by NES Partners, Climate Change Capital, Scottish Equity Partners.

The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Advanced Materials, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Nujira, Borean Pharma, BioStratum. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
19
Lead investments
3
Exits
7
Rounds per year
0.54
Follow on index
0.16
Investments by industry
  • Pharmaceutical (8)
  • Health Care (7)
  • Manufacturing (6)
  • Biotechnology (6)
  • Solar (4)
  • Show 30 more
Investments by region
  • Germany (2)
  • United States (6)
  • Denmark (7)
  • United Kingdom (4)
Peak activity year
2008

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
65M
Group Appearance index
0.95
Avg. company exit year
14
Avg. multiplicator
4.41
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
MedTrace Pharma 12 May 2021 Health Care, Health Diagnostics, Medical Device, Life Science, Pharmaceutical Early Stage Venture 28M Hovedstaden, Lyngby, Denmark

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.